CHU Clermont-Ferrand France
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for CHU Clermont-Ferrand published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
6 | 0.42 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 6 | 0.42 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.28 | 0.41 | 0.16 | 0.24 | 0.72 |
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 65.61% Domestic
- 34.39% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with CHU Clermont-Ferrand by Share (48 total)
-
CHU Clermont-Ferrand and Génétique, Reproduction et Développement (GReD)
(1.54)
-
CHU Clermont-Ferrand and University Clermont Auvergne
(0.94)
-
CHU Clermont-Ferrand and National Institute for Health and Medical Research (INSERM)
(0.90)
-
CHU Clermont-Ferrand and French National Centre for Scientific Research (CNRS)
(0.73)
-
CHU Clermont-Ferrand and Rennes University Hospital (CHU Rennes)
(0.44)
-
CHU Clermont-Ferrand and Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC)
(0.27)
-
CHU Clermont-Ferrand and Centre Hospitalier Universitaire de Lille (CHU Lille)
(0.25)
-
CHU Clermont-Ferrand and University of Paris
(0.19)
-
CHU Clermont-Ferrand and Maladies Rares du Developpement Embryonnaire et du Metabolisme : du Phénotype au Génotype et à la Fonction (RADEME)
(0.19)
-
CHU Clermont-Ferrand and Assistance Publique-Hôpitaux de Paris (AP-HP)
(0.19)
Top 10 international collaborators with CHU Clermont-Ferrand by Share (33 total)
-
CHU Clermont-Ferrand and Radboud University Nijmegen (RU)
(0.55)
-
CHU Clermont-Ferrand and Loma Linda University (LLU)
(0.47)
-
CHU Clermont-Ferrand and Amsterdam UMC
(0.28)
-
CHU Clermont-Ferrand and Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC)
(0.22)
-
CHU Clermont-Ferrand and University of Lausanne (UNIL)
(0.19)
-
CHU Clermont-Ferrand and National Institutes of Health (NIH)
(0.17)
-
CHU Clermont-Ferrand and University of Amsterdam (UvA)
(0.15)
-
CHU Clermont-Ferrand and VU Amsterdam
(0.15)
-
CHU Clermont-Ferrand and University of Oulu
(0.14)
-
CHU Clermont-Ferrand and Spanish National Research Council (CSIC)
(0.11)
Relationships
CHU Clermont-Ferrand
- CHU Gabriel-Montpied
- Infection Inflammation et Interaction Hôtes Pathogènes (3IHP), CHU Clermont-Ferrand
- Laboratoire de Virologie, CHU Clermont-Ferrand
Affiliated joint institutions and consortia
- Centre National de Référence (CNR) de la Résistance aux Antibiotiques
- Centre de Recherche en Nutrition Humaine d’Auvergne (CRNH Auvergne)
- International Parkinson Disease Genomics Consortium (IPDGC)
- Role of Intra-Clonal Heterogeneity and Leukemic Environment in Therapy Resistance of Chronic Leukemias (CHELTER)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.